HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

O Riess Selected Research

alpha-Synuclein

10/2012Impaired olfactory bulb neurogenesis depends on the presence of human wild-type alpha-synuclein.
7/2008Microarray expression analysis reveals genetic pathways implicated in C621 synphilin-1-mediated toxicity.
12/2006Mutation analysis of the seven in absentia homolog 1 (SIAH1) gene in Parkinson's disease.
9/2005The role of alpha-synuclein gene multiplications in early-onset Parkinson's disease and dementia with Lewy bodies.
1/2003Polymorphisms of the alpha-synuclein promoter: expression analyses and association studies in Parkinson's disease.
9/2001Evaluation of the gamma-synuclein gene in German Parkinson's disease patients.
6/2001Expression of alpha-synuclein in non-apoptotic, slowly degenerating facial motoneurones.
5/2001Familial parkinsonism with synuclein pathology: clinical and PET studies of A30P mutation carriers.
4/2000Genetic influence on the development of Parkinson's disease.
1/2000Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


O Riess Research Topics

Disease

17Parkinson Disease (Parkinson's Disease)
04/2014 - 01/2000
5Ataxia (Dyssynergia)
04/2014 - 08/2000
4Spinocerebellar Ataxias (Spinocerebellar Ataxia)
04/2014 - 07/2000
3Huntington Disease (Huntington's Disease)
01/2019 - 03/2004
3Alzheimer Disease (Alzheimer's Disease)
07/2003 - 01/2000
2Friedreich Ataxia (Friedreich's Ataxia)
04/2014 - 08/2000
2Dystonia musculorum deformans type 1
05/2010 - 12/2008
2Dystonia (Limb Dystonia)
05/2010 - 03/2001
2Neoplasms (Cancer)
07/2008 - 12/2004
2Dementia (Dementias)
09/2005 - 01/2000
2Neurodegenerative Diseases (Neurodegenerative Disease)
06/2001 - 01/2000
2Parkinsonian Disorders (Parkinsonism)
05/2001 - 10/2000
2Multiple System Atrophy
08/2000 - 01/2000
1Atrophy
01/2019
1SHORT syndrome
09/2014
1Vitamin E Deficiency
04/2014
1Disease Progression
04/2014
1Spastic ataxia Charlevoix-Saguenay type
04/2014
1autosomal recessive 1 Spinocerebellar ataxia
04/2014
1Ataxia Telangiectasia (Louis Bar Syndrome)
04/2014
1Synucleinopathies
10/2012
1Dystonic Disorders (Writer's Cramp)
12/2008
1Neuroblastoma
05/2008
1Trisomy (Trisomies)
01/2007
1Lewy Body Disease (Lewy Body Dementia)
09/2005
1Multiple Organ Failure (MODS)
12/2004
1Hepatic Encephalopathy
12/2004
1Sleepiness
12/2004
1Dihydropyrimidine Dehydrogenase Deficiency
12/2004
1Myoclonus (Nocturnal Myoclonus)
12/2004
1Cardiogenic Shock
12/2004
1Basal Ganglia Diseases (Basal Ganglia Disease)
11/2004
1Panic Disorder (Panic Attack)
12/2000
1Confusion (Bewilderment)
10/2000
1Absence Epilepsy (Childhood Absence Epilepsy)
06/2000
1Juvenile Myoclonic Epilepsy
06/2000
1Seizures (Absence Seizure)
06/2000
1Mitochondrial Diseases (Mitochondrial Disease)
04/2000
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2000
1Amyloid Plaque
01/2000

Drug/Important Bio-Agent (IBA)

10alpha-SynucleinIBA
10/2012 - 01/2000
3Proteins (Proteins, Gene)FDA Link
07/2008 - 12/2006
2Amino AcidsFDA Link
09/2014 - 05/2001
2OligonucleotidesIBA
05/2010 - 01/2007
2IronIBA
11/2004 - 04/2004
2tributyl phosphate (TBP)IBA
03/2004 - 03/2001
2polyglutamineIBA
10/2001 - 07/2000
1CaspasesIBA
01/2019
1mortalinIBA
04/2014
1CalciumIBA
04/2014
1Biomarkers (Surrogate Marker)IBA
04/2014
1idebenoneIBA
04/2014
1EndocannabinoidsIBA
06/2011
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
06/2011
1NucleotidesIBA
12/2008
1DNA (Deoxyribonucleic Acid)IBA
12/2008
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2008
1Transforming Growth Factor beta (TGF-beta)IBA
07/2008
1Phosphotransferases (Kinase)IBA
05/2008
1Leucine-Rich Repeat ProteinsIBA
05/2008
1Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
12/2004
1Leucovorin (Folinic Acid)FDA Link
12/2004
1Fluorouracil (Carac)FDA LinkGeneric
12/2004
1Ceruloplasmin (Ferroxidase)IBA
11/2004
1Synaptotagmins (Synaptotagmin)IBA
01/2004
1Cathepsin DIBA
07/2003
1ApolipoproteinsIBA
07/2003
1Aspartic Acid ProteasesIBA
07/2003
1ropinirole (Requip)FDA LinkGeneric
10/2002
1Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
01/2002
1AntibodiesIBA
01/2002
1Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA
10/2001
1Q-Type Calcium Channels (Q-Type Calcium Channel)IBA
10/2001
1Potassium Channels (Potassium Channel)IBA
10/2001
1gamma-Synuclein (Persyn)IBA
09/2001
1Proline (L-Proline)FDA Link
05/2001
1Alanine (L-Alanine)FDA Link
05/2001
1Adenosine Diphosphate (ADP)IBA
05/2001
1SynucleinsIBA
05/2001
1TATA-Box Binding Protein (TATA-Binding Protein)IBA
03/2001
1GABA-B ReceptorsIBA
12/2000
1Levodopa (L Dopa)FDA LinkGeneric
10/2000
1Protease Inhibitors (Protease Inhibitor)IBA
08/2000
1Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA
08/2000
1FrataxinIBA
08/2000
1Ataxin-2IBA
07/2000
1Immunoglobulin E (IgE)IBA
06/2000
1XenobioticsIBA
04/2000
1Dopamine (Intropin)FDA LinkGeneric
04/2000

Therapy/Procedure

2Therapeutics
04/2014 - 10/2000
1Drug Therapy (Chemotherapy)
12/2004